XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -69.08%101.84M | -69.08%101.84M | 55.19%54.97M | 110.16%48.68M | 584.40%293.77M | 505.60%329.39M | 505.60%329.39M | 20.45%35.42M | -53.51%23.16M | -12.51%42.92M |
-Cash and cash equivalents | -48.89%101.84M | -48.89%101.84M | 55.19%54.97M | 110.16%48.68M | 280.25%163.21M | 266.33%199.25M | 266.33%199.25M | 20.45%35.42M | -53.51%23.16M | -12.51%42.92M |
-Short-term investments | --0 | --0 | --0 | --0 | --130.55M | --130.14M | --130.14M | ---- | ---- | ---- |
Receivables | 2.40%87.81M | 2.40%87.81M | 1.14%86.28M | 7.53%87.73M | 11.53%87.59M | 15.22%85.75M | 15.22%85.75M | 18.73%85.3M | 16.54%81.59M | 10.93%78.54M |
-Accounts receivable | -61.48%2.05M | -61.48%2.05M | -74.19%1.71M | -42.09%2.88M | 9.76%4.55M | 75.81%5.33M | 75.81%5.33M | 173.54%6.64M | 90.86%4.97M | 3.71%4.14M |
-Other receivables | 6.64%85.76M | 6.64%85.76M | 7.50%84.56M | 10.75%84.86M | 11.63%83.05M | 12.65%80.42M | 12.65%80.42M | 13.32%78.67M | 13.67%76.62M | 11.36%74.39M |
Restricted cash | 9.72%237K | 9.72%237K | 9.95%232K | 82.26%226K | 85.00%222K | 86.21%216K | 86.21%216K | 86.73%211K | 13.76%124K | 14.29%120K |
Total current assets | -55.27%189.88M | -55.27%189.88M | 93.19%256.22M | -1.24%152.61M | 145.20%406.7M | 117.30%424.52M | 117.30%424.52M | -24.27%132.62M | -34.10%154.52M | -26.81%165.86M |
Non current assets | ||||||||||
Net PPE | -14.78%16.48M | -14.78%16.48M | -21.05%16.1M | -21.36%17.25M | -20.39%18.28M | -19.36%19.34M | -19.36%19.34M | -18.42%20.39M | -15.61%21.94M | -14.89%22.97M |
-Gross PPE | -14.78%16.48M | -14.78%16.48M | -21.05%16.1M | -21.36%17.25M | -20.39%18.28M | -19.36%19.34M | -19.36%19.34M | -18.42%20.39M | -15.61%21.94M | -14.89%22.97M |
Goodwill and other intangible assets | -2.17%245.69M | -2.17%245.69M | -6.20%298.81M | -4.73%310.99M | -5.36%310.99M | 61.85%251.13M | 61.85%251.13M | -4.24%318.55M | -1.87%326.42M | -3.13%328.61M |
-Other intangible assets | -2.17%245.69M | -2.17%245.69M | -6.20%298.81M | -4.73%310.99M | -5.36%310.99M | 61.85%251.13M | 61.85%251.13M | -4.24%318.55M | -1.87%326.42M | -3.13%328.61M |
Investments and advances | -64.26%40.02M | -64.26%40.02M | -3.56%111.14M | -1.09%111.78M | -2.78%111.07M | -6.26%111.96M | -6.26%111.96M | 107.95%115.24M | 29.69%113.01M | 55.29%114.25M |
Non current deferred assets | 13.75%39.82M | 13.75%39.82M | 19.37%37.42M | 17.35%37.04M | 39.49%35.55M | 38.88%35.01M | 38.88%35.01M | 22.63%31.35M | 39.50%31.57M | 16.69%25.49M |
Other non current assets | 16.68%20.76M | 16.68%20.76M | -45.22%17.85M | -12.76%24.05M | -8.28%24.17M | -26.82%17.79M | -26.82%17.79M | 25.02%32.58M | 31.99%27.56M | 53.00%26.35M |
Total non current assets | -3.05%3.65B | -3.05%3.65B | -5.23%3.6B | -1.96%3.73B | -2.33%3.75B | -2.34%3.77B | -2.34%3.77B | -1.04%3.8B | -0.31%3.81B | 2.08%3.84B |
Total assets | -8.33%3.84B | -8.33%3.84B | -1.91%3.85B | -1.93%3.89B | 3.78%4.16B | 3.43%4.19B | 3.43%4.19B | -2.05%3.93B | -2.27%3.96B | 0.44%4.01B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 0.64%98.22M | 0.64%98.22M | 4.34%99.75M | 0.76%103.44M | 5.77%100.84M | -13.39%97.59M | -13.39%97.59M | -22.15%95.6M | -12.53%102.66M | -6.83%95.33M |
-accounts payable | -1.60%57.06M | -1.60%57.06M | 4.74%60.01M | -1.03%63.74M | 7.16%61.26M | -21.92%57.98M | -21.92%57.98M | -34.91%57.3M | -21.26%64.4M | -12.76%57.17M |
-Dividends payable | 3.92%41.16M | 3.92%41.16M | 3.75%39.74M | 3.78%39.71M | 3.69%39.57M | 3.11%39.61M | 3.11%39.61M | 10.14%38.3M | 7.54%38.26M | 3.75%38.16M |
Current accrued expenses | -7.58%10.52M | -7.58%10.52M | 45.43%15.53M | 23.47%10.79M | 75.01%18.26M | 23.94%11.38M | 23.94%11.38M | 3.92%10.68M | 9.92%8.74M | 1.78%10.43M |
Current deferred liabilities | -0.75%26.67M | -0.75%26.67M | 0.68%25.59M | -9.74%22.15M | -0.76%26.75M | 0.76%26.87M | 0.76%26.87M | -3.81%25.42M | -0.94%24.54M | -2.81%26.95M |
Other current liabilities | ---- | ---- | -85.69%155K | -98.59%24K | -67.07%622K | -63.74%417K | -63.74%417K | -61.53%1.08M | -66.58%1.7M | -51.30%1.89M |
Current liabilities | -0.63%135.41M | -0.63%135.41M | 6.21%141.03M | -0.90%136.4M | 8.81%146.46M | -8.96%136.26M | -8.96%136.26M | -54.58%132.78M | -49.98%137.64M | -6.64%134.61M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -12.27%1.46B | -12.27%1.46B | 6.19%1.46B | 6.00%1.46B | 20.23%1.66B | 20.05%1.66B | 20.05%1.66B | -1.04%1.37B | -0.98%1.38B | -0.95%1.38B |
-Long term debt | -12.23%1.44B | -12.23%1.44B | 6.62%1.44B | 6.46%1.44B | 20.96%1.64B | 20.78%1.64B | 20.78%1.64B | -0.71%1.35B | -0.69%1.36B | -0.67%1.36B |
-Long term capital lease obligation | -15.42%17.11M | -15.42%17.11M | -21.23%16.75M | -21.35%17.94M | -20.81%18.99M | -19.45%20.23M | -19.45%20.23M | -18.39%21.27M | -15.48%22.81M | -14.45%23.99M |
Preferred securities outside stock equity | 0.08%127.89M | 0.08%127.89M | 0.08%127.87M | 0.08%127.84M | 0.08%127.82M | 0.08%127.79M | 0.08%127.79M | 0.08%127.77M | 0.08%127.74M | 0.08%127.72M |
Total non current liabilities | -11.39%1.59B | -11.39%1.59B | 5.67%1.59B | 5.50%1.59B | 18.53%1.79B | 18.36%1.79B | 18.36%1.79B | -0.94%1.5B | -0.89%1.51B | -0.87%1.51B |
Total liabilities | -10.63%1.72B | -10.63%1.72B | 5.72%1.73B | 4.97%1.73B | 17.73%1.94B | 15.90%1.93B | 15.90%1.93B | -9.61%1.63B | -8.42%1.64B | -1.36%1.64B |
Shareholders'equity | ||||||||||
Share capital | 0.00%94.05M | 0.00%94.05M | 0.00%94.05M | 0.00%94.05M | 0.00%94.05M | 0.00%94.05M | 0.00%94.05M | 0.00%94.05M | 0.00%94.05M | 0.00%94.05M |
-common stock | 0.00%29K | 0.00%29K | 0.00%29K | 0.00%29K | 0.00%29K | 0.00%29K | 0.00%29K | 3.57%29K | 3.57%29K | 0.00%29K |
-Preferred stock | 0.00%94.02M | 0.00%94.02M | 0.00%94.02M | 0.00%94.02M | 0.00%94.02M | 0.00%94.02M | 0.00%94.02M | 0.00%94.02M | 0.00%94.02M | 0.00%94.02M |
Retained earnings | -9.58%-1.32B | -9.58%-1.32B | -11.20%-1.31B | -10.76%-1.28B | -12.27%-1.24B | -11.37%-1.2B | -11.37%-1.2B | -9.06%-1.18B | -7.82%-1.15B | -2.87%-1.11B |
Paid-in capital | -0.46%3.32B | -0.46%3.32B | -0.37%3.31B | -0.38%3.31B | 0.23%3.33B | 0.31%3.33B | 0.31%3.33B | 6.06%3.32B | 4.16%3.32B | 1.79%3.32B |
Gains losses not affecting retained earnings | -35.29%6.14M | -35.29%6.14M | -82.47%2.52M | -61.75%6.2M | -40.55%8.42M | -46.39%9.48M | -46.39%9.48M | -19.17%14.36M | 69.49%16.2M | 135.84%14.17M |
Total stockholders'equity | -5.99%2.1B | -5.99%2.1B | -6.92%2.1B | -6.43%2.13B | -5.77%2.19B | -5.13%2.23B | -5.13%2.23B | 4.10%2.26B | 2.51%2.28B | 1.56%2.32B |
Noncontrolling interests | -32.60%22.49M | -32.60%22.49M | -32.13%25.9M | -30.51%26.34M | -16.42%31.96M | -12.80%33.37M | -12.80%33.37M | 7.88%38.16M | 9.10%37.9M | 13.61%38.24M |
Total equity | -6.39%2.12B | -6.39%2.12B | -7.34%2.13B | -6.82%2.16B | -5.94%2.22B | -5.25%2.27B | -5.25%2.27B | 4.16%2.29B | 2.61%2.32B | 1.74%2.36B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |